<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35025139</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1552-4833</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>188</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>American journal of medical genetics. Part A</Title>
          <ISOAbbreviation>Am J Med Genet A</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Expanded cardiovascular phenotype of Myhre syndrome includes tetralogy of Fallot suggesting a role for SMAD4 in human neural crest defects.</ArticleTitle>
        <Pagination>
          <StartPage>1384</StartPage>
          <EndPage>1395</EndPage>
          <MedlinePgn>1384-1395</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ajmg.a.62645</ELocationID>
        <Abstract>
          <AbstractText>Tetralogy of Fallot (ToF) can be associated with a wide range of extracardiac anomalies, with an underlying etiology identified in approximately 10% of cases. Individuals affected with Myhre syndrome due to recurrent SMAD4 mutations frequently have cardiovascular anomalies, including congenital heart defects. In addition to two patients in the literature with ToF, we describe five additional individuals with Myhre syndrome and classic ToF, ToF with pulmonary atresia and multiple aorto-pulmonary collaterals, and ToF with absent pulmonary valve. Aorta hypoplasia was documented in one patient and suspected in another two. In half of these individuals, postoperative cardiac dysfunction was thought to be more severe than classic postoperative ToF repair. There may be an increase in right ventricular pressure, and right ventricular dysfunction due to free pulmonic regurgitation. Noncardiac developmental abnormalities in our series and the literature, including corectopia, heterochromia iridis, and congenital miosis suggest an underlying defect of neural crest cell migration in Myhre syndrome. We advise clinicians that Myhre syndrome should be considered in the genetic evaluation of a child with ToF, short stature, unusual facial features, and developmental delay, as these children may be at risk for increased postoperative morbidity. Additional research is needed to investigate the hypothesis that postoperative hemodynamics in these patients may be consistent with restrictive myocardial physiology.</AbstractText>
          <CopyrightInformation>© 2022 Wiley Periodicals LLC.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Cappuccio</LastName>
            <ForeName>Gerarda</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">0000-0003-3934-2342</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Translational Medicine, Section of Pediatrics, Federico II University, Naples, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Telethon Institute of Genetics and Medicine, Pozzuoli (Naples), Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brunetti-Pierri</LastName>
            <ForeName>Nicola</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">0000-0002-6895-8819</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Translational Medicine, Section of Pediatrics, Federico II University, Naples, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Telethon Institute of Genetics and Medicine, Pozzuoli (Naples), Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Clift</LastName>
            <ForeName>Paul</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Adult Congenital Heart Disease Unit, University Hospitals Birmingham, Birmingham, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Learn</LastName>
            <ForeName>Christopher</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Adult Congenital Heart Disease Program, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dykes</LastName>
            <ForeName>John C</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Pediatrics, Stanford, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mercer</LastName>
            <ForeName>Catherine L</ForeName>
            <Initials>CL</Initials>
            <AffiliationInfo>
              <Affiliation>Wessex Clinical Genetics Service, University Hospital Southampton NHS Foundation Trust, Princess Anne Hospital, Southampton, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Callewaert</LastName>
            <ForeName>Bert</ForeName>
            <Initials>B</Initials>
            <Identifier Source="ORCID">0000-0002-9743-4205</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Meerschaut</LastName>
            <ForeName>Ilse</ForeName>
            <Initials>I</Initials>
            <Identifier Source="ORCID">0000-0001-5502-0568</Identifier>
            <AffiliationInfo>
              <Affiliation>Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Ghent University Hospital, Ghent, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Spinelli</LastName>
            <ForeName>Alessandro Mauro</ForeName>
            <Initials>AM</Initials>
            <Identifier Source="ORCID">0000-0003-1902-8209</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bruno</LastName>
            <ForeName>Irene</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gillespie</LastName>
            <ForeName>Matthew J</ForeName>
            <Initials>MJ</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dorfman</LastName>
            <ForeName>Aaron T</ForeName>
            <Initials>AT</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grimberg</LastName>
            <ForeName>Adda</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lindsay</LastName>
            <ForeName>Mark E</ForeName>
            <Initials>ME</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Division of Pediatric Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Cardiovascular Research Center, Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Angela E</ForeName>
            <Initials>AE</Initials>
            <Identifier Source="ORCID">0000-0002-1145-4572</Identifier>
            <AffiliationInfo>
              <Affiliation>Genetics Unit, Department of Pediatrics, MassGeneral Hospital for Children, Boston, Massachusetts, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>13</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Am J Med Genet A</MedlineTA>
        <NlmUniqueID>101235741</NlmUniqueID>
        <ISSNLinking>1552-4825</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C497796">SMAD4 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051901">Smad4 Protein</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <SupplMeshList>
        <SupplMeshName Type="Disease" UI="C537620">Growth mental deficiency syndrome of Myhre</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003456" MajorTopicYN="N">Cryptorchidism</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019066" MajorTopicYN="N">Facies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006130" MajorTopicYN="N">Growth Disorders</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006228" MajorTopicYN="N">Hand Deformities, Congenital</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006330" MajorTopicYN="Y">Heart Defects, Congenital</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008607" MajorTopicYN="N">Intellectual Disability</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009432" MajorTopicYN="N">Neural Crest</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051901" MajorTopicYN="N">Smad4 Protein</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013771" MajorTopicYN="Y">Tetralogy of Fallot</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Myhre syndrome</Keyword>
        <Keyword MajorTopicYN="N">SMAD4</Keyword>
        <Keyword MajorTopicYN="N">conotruncal heart defects</Keyword>
        <Keyword MajorTopicYN="N">neural crest</Keyword>
        <Keyword MajorTopicYN="N">restrictive cardiomyopathy</Keyword>
        <Keyword MajorTopicYN="N">tetralogy of Fallot</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>13</Day>
          <Hour>13</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35025139</ArticleId>
        <ArticleId IdType="doi">10.1002/ajmg.a.62645</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Akula, M., Park, J. W., &amp; West-Mays, J. A. (2019). Relationship between neural crest cell specification and rare ocular diseases. Journal of Neuroscience Research, 97(1), 7-15. https://doi.org/10.1002/jnr.24245</Citation>
        </Reference>
        <Reference>
          <Citation>Alagia, M., Cappuccio, G., Pinelli, M., Torella, A., Brunetti-Pierri, R., Simonelli, F., Limongelli, G., Oppido, G., Nigro, V., &amp; Brunetti-Pierri, N. (2018). A child with Myhre syndrome presenting with corectopia and tetralogy of Fallot. American Journal of Medical Genetics, Part A, 176(2), 426-430. https://doi.org/10.1002/ajmg.a.38560</Citation>
        </Reference>
        <Reference>
          <Citation>Brazel, S. M. (1992). Iris sector heterochromia as a marker for neural crest disease. Archives of Ophthalmology, 110(2), 233-235. https://doi.org/10.1001/archopht.1992.01080140089033</Citation>
        </Reference>
        <Reference>
          <Citation>Cappuccio, G., Caiazza, M., Roca, A., Melis, D., Iuliano, A., Matyas, G., Limongelli, G., &amp; Brunetti-Pierri, N. (2021). A pilot clinical trial with losartan in Myhre syndrome. American Journal of Medical Genetics. Part A., 185, 702-709. https://doi.org/10.1002/ajmg.a.62019</Citation>
        </Reference>
        <Reference>
          <Citation>Caputo, V., Cianetti, L., Niceta, M., Carta, C., Ciolfi, A., Bocchinfuso, G., Carrani, E., Dentici, M. L., Biamino, E., Belligni, E., Garavelli, L., Boccone, L., Melis, D., Andria, G., Gelb, B., Stella, L., Silengo, M., Dallapiccola, B., &amp; Tartaglia, M. (2012). A restricted Spectrum of mutations in the SMAD4 tumor-suppressor gene underlies Myhre syndrome. The American Journal of Human Genetics, 90(1), 161-169. https://doi.org/10.1016/j.ajhg.2011.12.011</Citation>
        </Reference>
        <Reference>
          <Citation>Domnina, Y. A., Koh, W., Lopez-Magallon, A., Morell, V. O., da Silva, J. P., Kazmerski, T. M., &amp; Chrysostomou, C. (2020). Tetralogy of Fallot with pulmonary atresia. In Critical Care of Children with heart disease (pp. 205-212). Springer International Publishing. https://doi.org/10.1007/978-3-030-21870-6_20</Citation>
        </Reference>
        <Reference>
          <Citation>Dundr, P., Povýsil, C., &amp; Tvrdík, D. (2009). Actin expression in neural crest cell-derived tumors including schwannomas, malignant peripheral nerve sheath tumors, neurofibromas and melanocytic tumors. Pathology International, 59(2), 86-90. https://doi.org/10.1111/j.1440-1827.2008.02333.x</Citation>
        </Reference>
        <Reference>
          <Citation>Ferencz, C., Loffredo, C. A., Correa-Villasenor, A., &amp; Wilson, P. D. (1997). Genetic and environmental risk factors for major congenital heart disease: The Baltimore Washington infant study 1981-1989. Perspectives in Pediatric Cardiology, (pp. 59-102). Armonk, NY: Futura Publishing Co., Inc.</Citation>
        </Reference>
        <Reference>
          <Citation>Heald, B., Rigelsky, C., Moran, R., LaGuardia, L., O'Malley, M., Burke, C. A., &amp; Zahka, K. (2015). Prevalence of thoracic aortopathy in patients with juvenile polyposis syndrome-hereditary hemorrhagic telangiectasia due to SMAD4. American Journal of Medical Genetics. Part A, 167A(8), 1758-1762. https://doi.org/10.1002/ajmg.a.37093</Citation>
        </Reference>
        <Reference>
          <Citation>Hörer, J., Friebe, J., Schreiber, C., Kostolny, M., Cleuziou, J., Holper, K., &amp; Lange, R. (2005). Correction of tetralogy of Fallot and of pulmonary atresia with ventricular septal defect in adults. The Annals of Thoracic Surgery, 80(6), 2285-2291. https://doi.org/10.1016/j.athoracsur.2005.05.076</Citation>
        </Reference>
        <Reference>
          <Citation>Hutson, M. R., &amp; Kirby, M. L. (2007). Model systems for the study of heart development and disease. Cardiac neural crest and conotruncal malformations. Seminars in Cell &amp; Developmental Biology, 18(1), 101-110. https://doi.org/10.1016/j.semcdb.2006.12.004</Citation>
        </Reference>
        <Reference>
          <Citation>Jia, Q., McDill, B. W., Li, S.-Z., Deng, C., Chang, C.-P., &amp; Chen, F. (2007). Smad signaling in the neural crest regulates cardiac outflow tract remodeling through cell autonomous and non-cell autonomous effects. Developmental Biology, 311(1), 172-184. https://doi.org/10.1016/j.ydbio.2007.08.044</Citation>
        </Reference>
        <Reference>
          <Citation>Kalcheim, C. (2019). The neural crest: A remarkable model system for studying development and disease. Methods in Molecular Biology, 1976, 1-19. https://doi.org/10.1007/978-1-4939-9412-0_1</Citation>
        </Reference>
        <Reference>
          <Citation>Ko, S. O., Chung, I. H., Xu, X., Oka, S., Zhao, H., Cho, E. S., Deng, C., &amp; Chai, Y. (2007). Smad4 is required to regulate the fate of cranial neural crest cells. Developmental Biology, 312(1), 435-447. https://doi.org/10.1016/j.ydbio.2007.09.050</Citation>
        </Reference>
        <Reference>
          <Citation>Lalani, S. R., &amp; Belmont, J. W. (2014). Genetic basis of congenital cardiovascular malformations. European Journal of Medical Genetics, 57(8), 402-413. https://doi.org/10.1016/j.ejmg.2014.04.010</Citation>
        </Reference>
        <Reference>
          <Citation>Le Goff, C., Mahaut, C., Abhyankar, A., Le Goff, W., Serre, V., Afenjar, A., Destrée, A., di Rocco, M., Héron, D., Jacquemont, S., Marlin, S., Simon, M., Tolmie, J., Verloes, A., Casanova, J.-L., Munnich, A., &amp; Cormier-Daire, V. (2012). Mutations at a single codon in Mad homology 2 domain of SMAD4 cause Myhre syndrome. Nature Genetics, 44(1), 85-88. https://doi.org/10.1038/ng.1016</Citation>
        </Reference>
        <Reference>
          <Citation>Lewis, C. J., Hedberg-Buenz, A., DeLuca, A. P., Stone, E. M., Alward, W. L. M., &amp; Fingert, J. H. (2017). Primary congenital and developmental glaucomas. Human Molecular Genetics, 26(R1), R28-R36. https://doi.org/10.1093/hmg/ddx205</Citation>
        </Reference>
        <Reference>
          <Citation>Lim, J., Tu, X., Choi, K., Akiyama, H., Mishina, Y., &amp; Long, F. (2015). BMP-Smad4 signaling is required for precartilaginous mesenchymal condensation independent of Sox9 in the mouse. Developmental Biology, 400(1), 132-138. https://doi.org/10.1016/j.ydbio.2015.01.022</Citation>
        </Reference>
        <Reference>
          <Citation>Lin, A. E., Michot, C., Cormier-Daire, V., L'Ecuyer, T. J., Matherne, G. P., Barnes, B. H., Humberson, J., Edmondson, A., Zackai, E., O’Connor, M., Kaplan, J., Ebeid, M., Krier, J., Krieg, E. L., Ghoshhajra, B., &amp; Lindsay, M. E. (2016). Gain-of-function mutations in SMAD4 cause a distinctive repertoire of cardiovascular phenotypes in patients with Myhre syndrome. American Journal of Medical Genetics. Part A, 170(10), 2617-2631. https://doi.org/10.1002/ajmg.a.37739</Citation>
        </Reference>
        <Reference>
          <Citation>Lin, C.-J., Lin, C.-Y., Chen, C.-H., Zhou, B., &amp; Chang, C.-P. (2012). Partitioning the heart: Mechanisms of cardiac septation and valve development. Development (Cambridge, England), 139(18), 3277-3299. https://doi.org/10.1242/dev.063495</Citation>
        </Reference>
        <Reference>
          <Citation>Lindinger, A., Schwedler, G., &amp; Hense, H.-W. (2010). Prevalence of congenital heart defects in newborns in Germany: Results of the first registration year of the PAN study (July 2006 to June 2007). Klinische Pädiatrie, 222(05), 321-326. https://doi.org/10.1055/s-0030-1254155</Citation>
        </Reference>
        <Reference>
          <Citation>Meerschaut, I., Beyens, A., Steyaert, W., De Rycke, R., Bonte, K., De Backer, T., Janssens, S., Panzer, J., Plasschaert, F., De Wolf, D., &amp; Callewaert, B. (2019). Myhre syndrome: A first familial recurrence and broadening of the phenotypic spectrum. American Journal of Medical Genetics. Part A, 179(12), 2494-2499. https://doi.org/10.1002/ajmg.a.61377</Citation>
        </Reference>
        <Reference>
          <Citation>Michot, C., Le Goff, C., Mahaut, C., Afenjar, A., Brooks, A. S., Campeau, P. M., Destrée, A., Rocco, M., Donnai, D., Hennekam, R., Heron, D., Jacquemont, S., Kannu, P., Lin, A., Manouvrier-Hanu, S., Mansour, S., Marlin, S., McGowan, R., Murphy, H. R., … Cormier-Daire, V. (2014). Myhre and LAPS syndromes: Clinical and molecular review of 32 patients. European Journal of Human Genetics: EJHG, 22(11), 1272-1277. https://doi.org/10.1038/ejhg.2013.288</Citation>
        </Reference>
        <Reference>
          <Citation>Mort, R. L., Jackson, I. J., &amp; Patton, E. E. (2015). The melanocyte lineage in development and disease. Development (Cambridge, England), 142(4), 620-632. https://doi.org/10.1242/dev.106567. Erratum in: Development. 2015 Apr 1;142(7):1387. PMID: 25670789; PMCID: PMC4325379.</Citation>
        </Reference>
        <Reference>
          <Citation>Pauli, S., Bajpai, R., &amp; Borchers, A. (2017). CHARGEd with neural crest defects. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 175(4), 478-486. https://doi.org/10.1002/ajmg.c.31584</Citation>
        </Reference>
        <Reference>
          <Citation>Picco, P., Naselli, A., Pala, G., Marsciani, A., Buoncompagni, A., &amp; Martini, A. (2013). Recurrent pericarditis in Myhre syndrome. American Journal of Medical Genetics. Part A., 161A(5), 1164-1166. https://doi.org/10.1002/ajmg.a.35892</Citation>
        </Reference>
        <Reference>
          <Citation>Rauch, R., Hofbeck, M., Zweier, C., Koch, A., Zink, S., Trautmann, U., Hoyer, J., Kaulitz, R., Singer, H., &amp; Rauch, A. (2010). Comprehensive genotype-phenotype analysis in 230 patients with tetralogy of Fallot. Journal of Medical Genetics, 47(5), 321-331. https://doi.org/10.1136/jmg.2009.070391</Citation>
        </Reference>
        <Reference>
          <Citation>Reinhartz, O., Reddy, V. M., Petrossian, E., Suleman, S., Mainwaring, R. D., Rosenthal, D. N., Feinstein, J. A., Gulati, R., &amp; Hanley, F. L. (2006). Unifocalization of major aortopulmonary collaterals in single-ventricle patients. The Annals of Thoracic Surgery, 82(3), 934-939. https://doi.org/10.1016/j.athoracsur.2006.03.063</Citation>
        </Reference>
        <Reference>
          <Citation>Ritter, K. E., &amp; Martin, D. M. (2019). Neural crest contributions to the ear: Implications for congenital hearing disorders. Hearing Research, 376, 22-32. https://doi.org/10.1016/j.heares.2018.11.005</Citation>
        </Reference>
        <Reference>
          <Citation>Schulz, Y., Wehner, P., Opitz, L., Salinas-Riester, G., Bongers, E. M. H. F., van Ravenswaaij-Arts, C. M. A., Wincent, J., Schoumans, J., Kohlhase, J., Borchers, A., &amp; Pauli, S. (2014). CHD7, the gene mutated in CHARGE syndrome, regulates genes involved in neural crest cell guidance. Human Genetics, 133(8), 997-1009. https://doi.org/10.1007/s00439-014-1444-2</Citation>
        </Reference>
        <Reference>
          <Citation>Starr, L. J., Grange, D. K., Delaney, J. W., Yetman, A. T., Hammel, J. M., Sanmann, J. N., Perry, D., Schaefer, G. B., &amp; Olney, A. H. (2015). Myhre syndrome: Clinical features and restrictive cardiopulmonary complications. American Journal of Medical Genetics Part A, 167(12), 2893-2901. https://doi.org/10.1002/ajmg.a.37273</Citation>
        </Reference>
        <Reference>
          <Citation>van Steensel, M. A. M., Vreeburg, M., Steijlen, P. M., &amp; de Die-Smulders, C. (2005). Myhre syndrome in a female with previously undescribed symptoms: Further delineation of the phenotype. American Journal of Medical Genetics. Part A, 139A(2), 127-130. https://doi.org/10.1002/ajmg.a.30988</Citation>
        </Reference>
        <Reference>
          <Citation>Vega-Lopez, G. A., Cerrizuela, S., Tribulo, C., &amp; Aybar, M. J. (2018). Neurocristopathies: New insights 150 years after the neural crest discovery. Developmental Biology, 444, S110-S143. https://doi.org/10.1016/j.ydbio.2018.05.013</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, J., Greene, S. B., &amp; Martin, J. F. (2011). BMP signaling in congenital heart disease: New developments and future directions. Birth Defects Research. Part A, Clinical and Molecular Teratology, 91(6), 441-448. https://doi.org/10.1002/bdra.20785</Citation>
        </Reference>
        <Reference>
          <Citation>Whitaker, A. T., Berthet, E., Cantu, A., Laird, D. J., &amp; Alliston, T. (2017). Smad4 regulates growth plate matrix production and chondrocyte polarity. Biology Open, 6(3), 358-364. https://doi.org/10.1242/bio.021436</Citation>
        </Reference>
        <Reference>
          <Citation>Wolf, M., &amp; Basson, C. T. (2010). The molecular genetics of congenital heart disease: a review of recent developments. Current Opinion in Cardiology, 25(3), 192-197. https://doi.org/10.1097/hco.0b013e328337b4ce</Citation>
        </Reference>
        <Reference>
          <Citation>Yong, M. S., Yim, D., Brizard, C. P., Robertson, T., Bullock, A., d'Udekem, Y., &amp; Konstantinov, I. E. (2014). Long-term outcomes of patients with absent pulmonary valve syndrome: 38 years of experience. The Annals of Thoracic Surgery, 97(5), 1671-1677. https://doi.org/10.1016/j.athoracsur.2014.01.035</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang, E., Yang, J., Liu, Y., Hong, N., Xie, H., Fu, Q., Li, F., Chen, S., Yu, Y., &amp; Sun, K. (2020). MESP2 variants contribute to conotruncal heart defects by inhibiting cardiac neural crest cell proliferation. Journal of Molecular Medicine, 98(7), 1035-1048. https://doi.org/10.1007/s00109-020-01929-4</Citation>
        </Reference>
        <Reference>
          <Citation>Zucker, N., Rozin, I., Levitas, A., &amp; Zalzstein, E. (2004). Clinical presentation, natural history, and outcome of patients with the absent pulmonary valve syndrome. Cardiology in the Young, 14(4), 402-408. https://doi.org/10.1017/S1047951104004093</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
